Download presentation
Presentation is loading. Please wait.
Published byEthan Nichols Modified over 9 years ago
1
Emily A. Blumberg, MD Perelman School of Medicine at the University of Pennsylvania
2
Research Funding ◦ Achaogen ◦ Actelion ◦ Ansun ◦ Cubist/Merck ◦ Roche ◦ Viropharma/Shire DSMB ◦ Bristol Myers Squibb ◦ Pfizer American Board of Internal Medicine Test Development Committee
3
Deceased donor from India, CMV D-R+ Progressive weight loss since transplant Admitted with CVA Incidental finding of newly abnormal chest X- ray Never had fever and no respiratory symptoms Meds: Tacrolimus, prednisone, mycophenolate (held), tmp sulfa, valganciclovir, thymoglobulin induction Exam unremarkable Routine CBC and chemistries unremarkable
5
Review of exposures revealed extensive exposure to soil during gardening post transplantation LESSONS LEARNED Infections occur in the absence of fever and localizing symptoms Can be true even months-years post transplant Detailed history is important in making diagnoses
6
Fever, dyspnea, non productive cough Basiliximab induction, Tacrolimus, Mycophenolate, Prednisone maintenance Valganciclovir, Tmp sulfa prophylaxis Pulmonary rehab – exposed to influenza, started on oseltamivir Presented with progressive SOB/DOE for 3-4 weeks Initial BAL Klebsiella pneumoniae – treated with cefpodoxime Persistent dyspnea
8
BAL Klebsiella pneumonia Influenza A Treated with piperacillin tazobactam, treatment dose of oseltamivir Still symptomatic Repeat bronchoscopy
10
Review of donor chart revealed donor from the Dominican Republic Subsequent testing donor serology + for Strongyloides LESSONS LEARNED Recipient history isn’t the only one that matters Transplant patients can have more than one diagnosis concurrently Not always clear which is the most important one
11
Tacrolimus, azathioprine immunosuppression Trimethoprim sulfamethoxazole and acyclovir for prophylaxis Exam – fever, rash Labs – pancytopenia Normal liver function tests
12
Diagnosis by chimerism assay All microbiology testing negative initially, although expired due to persistent bacterial infection when profoundly neutropenic LESSONS LEARNED Not all fevers are infection GVHD, Drug fever, rejection, thromboses all may cause fever Physical exam and labs can be helpful Consider all the options and test broadly when the answer is not obvious
13
Organ Donor Recipient Blood Donor Hospital Community Pyogenic Bacteria “Opportunistic” Bacteria Community Acquired Viruses “Opportunistic” Viruses Fungi Parasites Protozoa
14
Cultures Differentiation of colonization from infection Viral nucleic acid tests Interpretation of low viral loads and negative results with high index of suspicion Fungal assays (e.g., galactomannan, beta D glucan, histoplasmosis antigen, cryptococcal antigen) Variable sensitivity and specificity based on site/dissemination
15
Pooled sensitivity and specificity of the galactomannan assay for diagnosis of invasive aspergillosis (IA). Christopher D. Pfeiffer et al. Clin Infect Dis. 2006;42:1417- 1727 © 2006 by the Infectious Diseases Society of America
16
Procalcitonin and Bacterial Infection in SOT Yu, et al.Transplant Proc. 2014;46:26-32 Pooled sensitivity 85% (95% CI 75%-92%), specificity 81% (95% CI 72%-88%)
17
Pro-peptide precursor of calcitonin released by multiple tissues in response to cytokines and endotoxin Biomarker associated with bacterial infection Also elevated with end stage organ disease (cirrhosis), pancreatitis, cardiogenic shock, trauma, ischemic bowel Levels affected by surgery, immunosuppression Cytolytics may lead to elevated levels Viral infections typically associated with lower levels Co-infections may yield confounding results Sandkovsky, et al. Clin Transplant 2015: 29: 689–696
18
Serial measurements can be used As clue to bacterial infections in the early post transplant period in patients who did not receive cytolytics As indicator of response to treatment May differentiate infection from rejection But Procalcitonin alone cannot diagnose infection Serial measurements may be important
19
There is currently no magic set of tests that will consistently identify who is infected (fever or no fever) Need to incorporate clinical judgment and physical examination
20
“Timeline” of infection post-transplant NOSOCOMIAL, TECHNICAL OPPORTUNIST IC COMMUNITY ACQUIRED CMV Aspergill us PCP HSV VZV EBV Nocardia Listeria Toxoplasmo sis Tuberculo sis Cryptococc us Endemic mycoses Treatment of rejection Courtesy of Dr. Brian Schwartz
21
Impact of OI prophylaxis on the post- transplant “timeline” CMV Aspergill us PCP HSV VZV EBV Nocardia Listeria Toxoplasmo sis Courtesy of Dr. Brian Schwartz
22
Testing should reflect clinical suspicion Include combination of radiography, non invasive testing, and biopsy Extensive diagnostics may be required unless diagnosis is clear Step wise testing may result in critical loss of time (especially since outcomes often linked to timing of initiation of appropriate antimicrobials) But is a broad approach cost effective? Histopathology may ultimately be the quickest reliable test!
23
Prompt initiation of appropriate antimicrobials makes a difference All antimicrobials come at a cost (not purely financial)
24
How strong is the suspicion regarding a specific diagnosis? Have I gotten sufficient samples so that antimicrobials will not affect diagnosis? What kind of testing will be most helpful? Will the testing have reduced sensitivity in transplant patients? How sick is the patient? What is the anticipated toxicity of the antimicrobials?
25
Fever usually (but not always) equals infection Not all infections are associated with fevers Transplant patients may be the exception to Occam’s Razor (single unifying diagnosis)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.